Skip to content

TRLV

Trulieve Cannabis Corp.

NYSE · Healthcare · Pharmaceuticals · US

$12.11
+1.00%
Ask drillr

Year over year

Reported trailing growth

Revenue
EBITDA
EBIT
EPS
Free cash flow
Operating cash flow

Forward estimates

Based on analyst estimates

Revenue
-19.5%
EBITDA
+332.8%
EPS
+118.9%

Three-year CAGR

Revenue
EBITDA
EBIT
Net income
EPS
Free cash flow

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026